Selinexor and Backbone Treatments of Multiple Myeloma Patients
Clinical trial NCT02343042 · RECRUITING
Trial details
- NCT number
- NCT02343042
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2027-04-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.